{
    "symbol": "OPRX",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-09 21:50:29",
    "content": " And then what I would say to you, even around the sort of Medicare patients is, the downward pressure ultimately is going to force more of a focus on volume, because pharma will be constrained to essentially get the same price capture that they've had in every script that's been written and so to maintain the same sort of level of trajectory on the profitability side, they're going to need to do more business in those areas."
}